Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future.

PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

pancreas adenocarcinoma

islet cell cancer

pancreatic cysts

pancreatitis (hereditary, acute, or chronic)

Disqualifiers

Under the age of 18

Unable to provide informed consent

Prison inmates

Trial population

Patients with known or suspected pancreas disease including pancreas adenocarcinoma, islet cell cancer, pancreatic cysts, pancreatitis (hereditary, acute, or chronic) or the next of kin of deceased participants.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • medical chart review

    Other intervention

    baseline, 12 month and 36 months

  • survey administration

    Other intervention

    baseline, 6 month, 12 month

  • biospecimen collection

    Other intervention

    baseline

Treatment groups

20,000 Participants
are divided into 1 treatment group
Group A: Observational3 interventions

Trial outcomes

Primary outcomes

1

Collection of clinical data, health and family histories by survey

Time frame
baseline enrollment, 6 months, 12 months
2

Collection of blood and/or tissue, fecal and oral specimens

Time frame
baseline
3

Collection of information regarding food preparation and intake by survey

Time frame
baseline

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mayo Clinic

Lead sponsor

National Cancer Institute (NCI)

Collaborator